Charles River Laboratories International (NYSE:CRL) Upgraded at Redburn Atlantic
Charles River Laboratories International (NYSE:CRL – Get Free Report) was upgraded by stock analysts at Redburn Atlantic from a “neutral” rating to a “buy” rating in a research report issued to clients and investors on Friday, MarketBeat reports. The firm presently has a $182.00 price target on the medical research company’s stock, down from their […]
Charles River Laboratories International (NYSE:CRL – Get Free Report) was upgraded by stock analysts at Redburn Atlantic from a “neutral” rating to a “buy” rating in a research report issued to clients and investors on Friday, MarketBeat reports. The firm presently has a $182.00 price target on the medical research company’s stock, down from their […]
